Skip to content

SI-BONE, Inc. SIBN Total Equity

Total Equity at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.67B+2.2%
Globus Medical logo
Globus MedicalGMED
$4.73B+15.8%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$5.35M+93.8%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
IAR
Integra LifeSciencesIART
$1.04B-31.6%
Bioventus logo
BioventusBVS
$188.9M+27.5%

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s total equity?
SI-BONE, Inc. (SIBN) reported total equity of $178.94M in Q1 2026.
How has SI-BONE, Inc.'s total equity changed year-over-year?
SI-BONE, Inc.'s total equity increased by 7.0% year-over-year, from $167.26M to $178.94M.
What is the long-term trend for SI-BONE, Inc.'s total equity?
Over 5 years (2020 to 2025), SI-BONE, Inc.'s total equity has grown at a 0.9% compound annual growth rate (CAGR), from $169.36M to $177.53M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.